22/08/2025
Synmosa selects KLN partner
The KLN logistics group has announced that its pharmaceutical subsidiary, KLN Pharma, has been appointed as fourth-party logistics (4PL) provider for Synmosa Biopharma in Hong Kong. Under the agreement, KLN Pharma will manage Synmosa’s end-to-end supply chain, covering inbound logistics, inventory management, order fulfilment, marketing logistics, distribution and regulatory support. The scope includes cardiovascular products requiring temperature-sensitive and time-critical handling, as Kln reported.
KLN aims to leverage its GMP-compliant facilities, multi-temperature storage, temperature-controlled fleet and proprietary inventory systems to ensure compliance and integrity. Samuel Lau, managing director integrated logistics Asia at KLN, said the 4PL model offers flexibility, compliance and scalability for Synmosa’s growth. (js)
